Literature DB >> 10226784

Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses.

T Petley1, K Graff, W Jiang, H Yang, J Florini.   

Abstract

This review compares the signaling pathways leading to cellular responses (primarily proliferation and differentiation) of cells to the insulin-like growth factors (IGFs). Although some systems (such as myoblasts and adipocytes) clearly employ the Ras-Raf-Mitogen Activated Protein (MAP) kinase pathway in signaling for cell proliferation, others (such as MCF-7 mammary tumors and brain capillary cells) proliferate in response to signals mediated by phosphatidylinositol-3 kinase and p70 S6 kinase. Similarly, most of the systems surveyed use a phosphatidylinositol-3 kinase pathway in differentiating in response to IGFs, but others (such as SH-SY5Y neuroblastoma cells) differentiate in response to the MAP kinase pathway. Thus, it seems that there are no simple generalizations that can be used to forecast the signaling pathway that will be involved in any response to the IGFs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226784     DOI: 10.1055/s-2007-978701

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  20 in total

Review 1.  Anticancer drug targets: growth factors and growth factor signaling.

Authors:  J B Gibbs
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome.

Authors:  David R Weber; Diana E Stanescu; Robert Semple; Cheryl Holland; Sheela N Magge
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

Review 3.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 4.  Function of the IGF-I receptor in breast cancer.

Authors:  E Surmacz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

Review 5.  Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity.

Authors:  S Giannini; B Cresci; C Manuelli; L Pala; C M Rotella
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

Review 6.  Placental glucose transfer and fetal growth.

Authors:  Marc U Baumann; Sylvie Deborde; Nicholas P Illsley
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

7.  Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cells.

Authors:  Florentina Pluteanu; Leanne L Cribbs
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-09       Impact factor: 4.249

8.  Renal carcinogenesis after uninephrectomy.

Authors:  Yi Sui; Hai-Lu Zhao; Heung Man Lee; Jing Guan; Lan He; Fernand Mm Lai; Peter Cy Tong; Juliana Cn Chan
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

9.  Anti-insulin growth factor receptor therapy in Ewing sarcoma.

Authors:  Michael S Isakoff; Neyssa Marina
Journal:  F1000 Med Rep       Date:  2009-08-17

10.  IGF2 knockdown in two colorectal cancer cell lines decreases survival, adhesion and modulates survival-associated genes.

Authors:  Michael A Rogers; Verena Kalter; Moritz Strowitzki; Martin Schneider; Peter Lichter
Journal:  Tumour Biol       Date:  2016-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.